Filter Results:
(729)
Show Results For
- All HBS Web
(729)
- People (1)
- News (202)
- Research (412)
- Multimedia (12)
- Faculty Publications (250)
Show Results For
- All HBS Web
(729)
- People (1)
- News (202)
- Research (412)
- Multimedia (12)
- Faculty Publications (250)
- Research Summary
Overview
The Information Age has introduced well-received opportunities to track performance. Fitbits and Fuelbands allow individuals to track their own performance; companies like Uber and leading hospitals help you choose a driver or a doctor based on how others rated... View Details
- November 2013 (Revised November 2014)
- Case
Infection Control at Massachusetts General Hospital
By: Robert S. Huckman and Nikolaos Trichakis
The case explores the challenges facing Massachusetts General Hospital concerning the adoption of a new infection control policy, which promises to improve operational performance, patient safety, and profitability. The new policy requires coordination between... View Details
Keywords: Safety; Organizational Change and Adaptation; Integration; Health Care and Treatment; Policy; Health Industry; Boston
Huckman, Robert S., and Nikolaos Trichakis. "Infection Control at Massachusetts General Hospital." Harvard Business School Case 614-044, November 2013. (Revised November 2014.)
- 25 May 2016
- Research & Ideas
How Consumers and Businesses are Reshaping Public Health
Editor's note. In the United States, a primary provider of health care is through employers. "Every corporation is a player in public health," writes John A. Quelch in a new book of case studies, Consumers, Corporations, and... View Details
- 20 Jul 2020
- Op-Ed
It's Time for a Bipartisan Health Plan for Employers and Employees
HRA-Public Option combination, employers that are now compelled to continually raise out-of-pocket expenses to employees to control health care costs will no longer be caught in the middle between the complaints of employees and the... View Details
- June 2020
- Article
Evaluation of Prescription Drug Monitoring Program Integration with Hospital Electronic Health Records by US County-Level Opioid Prescribing Rates
By: A Jay Holmgren and Nate Apathy
Prescription drug monitoring programs (PDMPs) have become a widely embraced policy solution to the opioid epidemic in the US. PDMPs offer prescribers a comprehensive view of patients’ controlled substance prescription history and can be used to monitor and reduce... View Details
Keywords: Prescription Drug Monitoring Programs; PDMPs; Electronic Health Records; Hospitals; Health Care and Treatment; Information Technology; Integration; Performance Evaluation
Holmgren, A Jay, and Nate Apathy. "Evaluation of Prescription Drug Monitoring Program Integration with Hospital Electronic Health Records by US County-Level Opioid Prescribing Rates." JAMA Network Open 3, no. 6 (June 2020).
- 03 Mar 2009
- First Look
First Look: March 3, 2009
control over pricing and associated revenues from the content to the content provider in order to reduce price competition at the platform level. Download the paper: http://www.hbs.edu/research/pdf/08-009.pdf Applying the Care Delivery... View Details
Keywords: Martha Lagace
- 07 Mar 2018
- Research & Ideas
Electronic Health Records Were Supposed to Cut Medical Costs. They Haven't.
$215 depending on the type of visit. That’s despite the fact that Duke has an established electronic health record (EHR) system and an efficient, centralized billing department, Kaplan says. Administrative costs account for at least a quarter of health View Details
- 05 Sep 2012
- What Do You Think?
Will Business Management Save US Health Care?
era of a medical star system is about over. Outstanding medical institutions like Mayo Clinic and Cleveland Clinic have long avoided it. They opt instead for hiring practitioners as employees who are paid... View Details
- December 2006 (Revised August 2008)
- Case
Pervasis Therapeutics, Inc.
By: Robert F. Higgins and Virginia Fuller
In May 2005, Steve Bollinger was about to become president and chief operating officer of Pervasis Therapeutics, a small cell therapy start-up in Cambridge, Mass. If proven successful, Pervasis' product, Vascugel, could change the way vascular disease is treated and... View Details
Keywords: Business Startups; Venture Capital; Financial Strategy; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Health Testing and Trials; Health Industry; Cambridge
Higgins, Robert F., and Virginia Fuller. "Pervasis Therapeutics, Inc." Harvard Business School Case 807-026, December 2006. (Revised August 2008.)
- 13 Aug 2024
- Op-Ed
Can AI Save Physicians from Burnout?
unease, and high turnover rates. Now, many health care organizations are turning to artificial intelligence (AI) as a potential solution to physician overwork and burnout. After all, AI offers long-sought-after benefits for clinicians,... View Details
- June 5, 2023
- Article
How to Tap the Full Potential of Telemedicine
By: Mitchell Tang, Louise Short, Ryan June, Matthew Dowling and Ateev Mehrotra
Telemedicine visits in the United States have fallen sharply since April 2020, but the end of the pandemic should not spell the end of telemedicine. It can play a valuable role in the delivery of health care. The key to tapping its potential is to bring many elements... View Details
Tang, Mitchell, Louise Short, Ryan June, Matthew Dowling, and Ateev Mehrotra. "How to Tap the Full Potential of Telemedicine." Harvard Business Review (website) (June 5, 2023).
- 29 Jun 2013
- News
Hospital operators and Obamacare: Prescription for change
- 16 Apr 2019
- First Look
New Research and Ideas, April 16, 2019
blindsided. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=55966 Winter 2019 International Anesthesiology Clinics Value-based Health Care: Lessons for the Anesthesiologist By: Martin, J.A., B.L. Potter, T.F. Flanagan,... View Details
Keywords: Dina Gerdeman
- September 2022
- Case
Proactive for Her
By: Rembrand Koning and Kairavi Dey
Proactive for Her began amid the COVID-19 pandemic, in August 2020 as a digital platform to provide accessible, evidence-based, primary, preventive non-judgmental healthcare services for Indian women, who were often dissuaded from seeking help as premarital sex and... View Details
Keywords: Women's Health; Healthcare; India; Start-up; Telehealth; Digital Platforms; Health Care and Treatment; Customer Focus and Relationships; Business Startups; Health Industry; Asia; South Asia; India
Koning, Rembrand, and Kairavi Dey. "Proactive for Her." Harvard Business School Case 723-351, September 2022.
- Article
Regulatory, Legal, and Market Aspects of Smart Wearables for Cardiac Monitoring
By: Jan Benedikt Brönneke, Jennifer Müller, Konstantinos Mouratis, Julia Hagen and Ariel Dora Stern
In the area of cardiac monitoring, the use of digitally driven technologies is on the rise. While the development of medical products is advancing rapidly, allowing for new use-cases in cardiac monitoring and other areas, regulatory and legal requirements that govern... View Details
Keywords: Wearables; Regulatory Changes; Medical Technology; Medical Devices; Market Access; Market Entry and Exit; Information Technology; Health Care and Treatment; Governing Rules, Regulations, and Reforms; United States; Germany; Belgium
Brönneke, Jan Benedikt, Jennifer Müller, Konstantinos Mouratis, Julia Hagen, and Ariel Dora Stern. "Regulatory, Legal, and Market Aspects of Smart Wearables for Cardiac Monitoring." Art. 4937. Sensors 21, no. 14 (July 2021).
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- 26 Feb 2019
- First Look
New Research and Ideas, February 26, 2019
compared to the distance to universities that offer only business or medical education (or neither). We argue that supplying joint MBA-healthcare courses may be a channel through which universities increase medical business skills and raise View Details
Keywords: Dina Gerdeman
- 01 Nov 2019
- News
Evolution of the consumer focus in healthcare
- 28 Nov 2016
- News
One Obstacle to Curing Cancer: Patient Data Isn’t Shared
- January 2018
- Article
Innovation Incentives and Biomarkers
By: Ariel Dora Stern, Brian M. Alexander and Amitabh Chandra
Previously, we have discussed the importance of economic incentives in shaping markets for precision medicines. Here we consider incentives for biomarker development, including discovery and establishment. Biomarkers can reveal valuable information regarding diagnosis... View Details
Stern, Ariel Dora, Brian M. Alexander, and Amitabh Chandra. "Innovation Incentives and Biomarkers." Clinical Pharmacology & Therapeutics 103, no. 1 (January 2018): 34–36.